BioStock Studio: CombiGene´s CEO provides an operational update

In connection with the release of Combigene’s year-end report for 2022, the gene therapy company’s CEO Jan Nilsson visited BioStock for a video interview. In addition to a review of the company’s ongoing projects, not least the recently initiated pain project with Danish Zyneyro, we get to know more about what is on the agenda for Combigene in 2023.

Watch the interview with CombiGene´s CEO Jan Nilsson at biostock.se:

https://www.biostock.se/en/2023/02/combigenes-ceo-provides-an-operational-update/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/